We are live on ! Find out more
PHP

Parkman Healthcare Partners Portfolio holdings

AUM $970M
1-Year Est. Return 79.46%
This Fund
S&P 500
This Quarter Est. Return
+7.79%
1 Year Est. Return
+79.46%
3 Year Est. Return
+312.89%
5 Year Est. Return
+648.59%
10 Year Est. Return
–
AUM
$453M
AUM Growth
+$57.9M
Cap. Flow
+$54.8M
Cap. Flow %
12.09%
Top 10 Hldgs %
36.96%
Holding
92
New
18
Increased
38
Reduced
28
Closed
8

Top Buys

Rank Stock Value
1
UNH icon
UnitedHealth
UNH
+$17.1M
2
HCA icon
HCA Healthcare
HCA
+$12.4M
3
CVS icon
CVS Health
CVS
+$12.3M
4
DHR icon
Danaher
DHR
+$4.2M
5
BCRX icon
BioCryst Pharmaceuticals
BCRX
+$3.94M

Top Sells

Rank Stock Value
1
HUM icon
Humana
HUM
+$7.39M
2
DXCM icon
DexCom
DXCM
+$7.21M
3
PODD icon
Insulet
PODD
+$5.03M
4
RCUS icon
Arcus Biosciences
RCUS
+$4.64M
5
CDMO
Avid Bioservices, Inc. Common Stock
CDMO
+$4.58M

Sector Composition

Rank Sector Weight
1 Healthcare 95.63%
2 Industrials 1.69%
3 Technology 0.21%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
ANGO icon
51
AngioDynamics
ANGO
$651M
$2.43M 0.54%
+87,969
New +$2.43M
ALT icon
52
Altimmune
ALT
$570M
$2.41M 0.53%
263,474
+88,474
+51% +$940K
SDGR icon
53
Schrodinger
SDGR
$1.39B
$2.36M 0.52%
67,792
+34,684
+105% +$1.58M
OM icon
54
Outset Medical
OM
$84.6M
$2.18M 0.48%
3,154
-202
-6% -$149K
TKNO icon
55
Alpha Teknova
TKNO
$397M
$2.15M 0.48%
105,208
+23,836
+29% +$529K
HCAT icon
56
Health Catalyst
HCAT
$135M
$2.09M 0.46%
52,678
+2,163
+4% +$98.6K
PHLT
57
DELISTED
Performant Healthcare Inc
PHLT
$2.05M 0.45%
850,000
-127,334
-13% -$379K
ETNB
58
DELISTED
89bio
ETNB
$1.99M 0.44%
152,098
+6,250
+4% +$98.8K
SMLR
59
DELISTED
Semler Scientific
SMLR
$1.96M 0.43%
21,419
-3,579
-14% -$401K
AXGN icon
60
Axogen
AXGN
$2.67B
$1.94M 0.43%
206,598
+6,598
+3% +$79.1K
AKYA
61
DELISTED
Akoya BioSciences
AKYA
$1.91M 0.42%
+125,000
New +$1.64M
MRTX
62
DELISTED
Mirati Therapeutics, Inc. Common Stock
MRTX
$1.89M 0.42%
+12,914
New +$2M
SIEN
63
DELISTED
Sientra, Inc.
SIEN
$1.8M 0.4%
49,169
+4,994
+11% +$242K
KRMD icon
64
KORU Medical Systems
KRMD
$152M
$1.79M 0.4%
597,610
+371,354
+164% +$1.14M
HALO icon
65
Halozyme
HALO
$11.6B
$1.66M 0.37%
+41,333
New +$1.54M
PHAT icon
66
Phathom Pharmaceuticals
PHAT
$742M
$1.52M 0.34%
+77,481
New +$1.82M
FMTX
67
DELISTED
Forma Therapeutics Holdings, Inc. Common Stock
FMTX
$1.42M 0.31%
+100,000
New +$1.73M
KNSA icon
68
Kiniksa Pharmaceuticals
KNSA
$6.1B
$1.34M 0.3%
+113,644
New +$1.4M
TELA icon
69
TELA Bio
TELA
$32.3M
$1.33M 0.29%
104,282
+4,282
+4% +$54.2K
ANAB icon
70
AnaptysBio
ANAB
$1.69B
$1.25M 0.27%
+35,833
New +$1.14M
SURF
71
DELISTED
Surface Oncology, Inc. Common Stock
SURF
$1.24M 0.27%
258,902
+10,635
+4% +$68.6K
MNKD icon
72
MannKind Corp
MNKD
$1.24B
$1.16M 0.26%
265,855
+10,808
+4% +$50K
SCTL
73
DELISTED
Societal CDMO, Inc. Common Stock
SCTL
$1.1M 0.24%
645,675
-125,158
-16% -$214K
RPID icon
74
Rapid Micro Biosystems
RPID
$84.8M
$1.06M 0.23%
+100,000
New +$1.56M
OPNT
75
DELISTED
Opiant Pharmaceuticals, Inc. Common Stock
OPNT
$1.05M 0.23%
31,291
+1,291
+4% +$36K
1 2
3
4

Similar funds

LOIM
Liberty One Investment Management Libertyville, Illinois $970M AUM 12.15% 1-Year Est. Return
MGCM
Mane Global Capital Management New York $971M AUM 58.5% 1-Year Est. Return
JWM
Jackson Wealth Management Lake Mary, Florida $972M AUM 22.58% 1-Year Est. Return
WAM
WNY Asset Management Williamsville, New York $967M AUM
GHC
Graham Holdings Company Arlington, Virginia $967M AUM 15.12% 1-Year Est. Return
SAM
Stansberry Asset Management Westlake, Texas $973M AUM 21.39% 1-Year Est. Return
TCCM
Two Creeks Capital Management New York $974M AUM 2.54% 1-Year Est. Return
UIC
Uniplan Investment Counsel Milwaukee, Wisconsin $974M AUM 21.37% 1-Year Est. Return

Parkman Healthcare Partners's Q4 2021 Portfolio in Review

As of Q4 2021, Parkman Healthcare Partners held 92 positions worth $453M, up 15% from $395M the previous quarter. Its ten largest holdings account for 37% of the portfolio.

Parkman Healthcare Partners deployed $54.8M of net new capital in Q4 2021, opening 18 new positions and adding to 38 existing holdings. Its largest new stake was UnitedHealth: 37,823 shares worth $19M.

By sector, the portfolio is most concentrated in Healthcare at 96% of assets, down from 98% a quarter earlier, followed by Industrials and Technology.

On the sell side, the largest reduction was DexCom, an estimated $7.21M trimmed.

  • Parkman Healthcare Partners's largest Q4 2021 buy was UnitedHealth: 37,823 shares worth $19M.
  • Parkman Healthcare Partners added most to Danaher in Q4 2021, an estimated $4.2M increase.
  • Parkman Healthcare Partners's biggest Q4 2021 reduction was DexCom, cutting an estimated $7.21M.
  • Parkman Healthcare Partners fully exited Humana in Q4 2021, selling an estimated $7.39M.
  • Parkman Healthcare Partners's ten largest holdings make up 37% of its $453M portfolio in Q4 2021.
  • Parkman Healthcare Partners opened 18 new positions and closed 8 in Q4 2021.
  • Parkman Healthcare Partners's portfolio value rose 15% quarter-over-quarter to $453M.

Based on Parkman Healthcare Partners's 13F filing for Q4 2021, filed 11 Feb 2022.